fexofenadine has been researched along with Dermatitis, Atopic in 11 studies
fexofenadine: a second generation antihistamine; metabolite of the antihistaminic drug terfenadine; structure in first source; RN refers to HCl
fexofenadine : A piperidine-based anti-histamine compound.
Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fexofenadine (n = 201) significantly decreased the severity of pruritus compared with placebo (n = 199) (mean change in score -0." | 9.10 | Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study. ( Harada, S; Inagi, M; Kawashima, M; Nakagawa, H; Noguchi, T; Tango, T, 2003) |
| "Fexofenadine (n = 201) significantly decreased the severity of pruritus compared with placebo (n = 199) (mean change in score -0." | 5.10 | Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study. ( Harada, S; Inagi, M; Kawashima, M; Nakagawa, H; Noguchi, T; Tango, T, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (81.82) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Ningombam, A | 1 |
| Handa, S | 1 |
| Srivastava, N | 1 |
| Mahajan, R | 1 |
| De, D | 1 |
| Izumi, N | 1 |
| Mizuguchi, H | 1 |
| Umehara, H | 1 |
| Ogino, S | 1 |
| Fukui, H | 1 |
| Funakushi, N | 1 |
| Yamaguchi, T | 1 |
| Jiang, J | 1 |
| Imamura, S | 1 |
| Kuhara, T | 1 |
| Suto, H | 1 |
| Ueki, R | 1 |
| Kase, Y | 1 |
| Kobayashi, H | 1 |
| Ogawa, H | 1 |
| Ikeda, S | 1 |
| Kawashima, M | 1 |
| Tango, T | 1 |
| Noguchi, T | 1 |
| Inagi, M | 1 |
| Nakagawa, H | 1 |
| Harada, S | 1 |
| Urabe, K | 1 |
| Nakahara, T | 1 |
| Moroi, Y | 1 |
| Morita, K | 1 |
| Furue, M | 1 |
| Jackson, CM | 1 |
| Lee, DK | 1 |
| Lipworth, BJ | 1 |
| Takahashi, H | 1 |
| Ishida-Yamamoto, A | 1 |
| Iizuka, H | 1 |
| Izu, K | 1 |
| Tokura, Y | 1 |
| Maier, T | 1 |
| Herzinger, T | 1 |
| Amon, U | 1 |
| Amon, S | 1 |
| Gibbs, BF | 1 |
| Purohit, A | 1 |
| Duvernelle, C | 1 |
| Melac, M | 1 |
| Pauli, G | 1 |
| Frossard, N | 1 |
6 trials available for fexofenadine and Dermatitis, Atopic
| Article | Year |
|---|---|
Addition of oral fexofenadine to topical therapy leads to a significantly greater reduction in the serum interleukin-31 levels in mild to moderate paediatric atopic dermatitis.
Topics: Administration, Topical; Child; Dermatitis, Atopic; Double-Blind Method; Humans; Interleukins; Prosp | 2022 |
Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study.
Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Dermatitis, Atopic; Dermatologic Agents; Double-Blind | 2003 |
Mite-antigen induced immediate reactions in atopic dermatitis are inhibited by daily administration of fexofenadine.
Topics: Administration, Oral; Adult; Animals; Antigens, Dermatophagoides; Dermatitis, Allergic Contact; Derm | 2003 |
The effects of butterbur on the histamine and allergen cutaneous response.
Topics: Acetates; Adult; Anti-Inflammatory Agents; Cross-Over Studies; Cyclopropanes; Dermatitis, Atopic; Do | 2004 |
Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance.
Topics: Adult; Cetirizine; Cross-Over Studies; Dermatitis, Atopic; Dibenzoxepins; Double-Blind Method; Femal | 2004 |
Twenty-four hours of activity of cetirizine and fexofenadine in the skin.
Topics: Adolescent; Adult; Anti-Allergic Agents; Cetirizine; Cross-Over Studies; Dermatitis, Atopic; Double- | 2001 |
5 other studies available for fexofenadine and Dermatitis, Atopic
| Article | Year |
|---|---|
Analysis of disease-dependent sedative profiles of H(1)-antihistamines by large-scale surveillance using the visual analog scale.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Asthma; Butyrophenones; Cetirizine; Child; Chlorpheniram | 2008 |
Ameliorating effect of Yokukansan on the development of atopic dermatitis-like lesions and scratching behavior in socially isolated NC/Nga mice.
Topics: Animals; Anti-Anxiety Agents; Dermatitis, Atopic; Drugs, Chinese Herbal; Excitatory Amino Acid Trans | 2011 |
The various effects of four H1-antagonists on serum substance P levels in patients with atopic dermatitis.
Topics: Adult; Anti-Allergic Agents; Cetirizine; Dermatitis, Atopic; Dibenzazepines; Dibenzoxepins; E-Select | 2005 |
[Linear dermatitis due to shiitake mushrooms].
Topics: Administration, Oral; Administration, Topical; Adult; Androstadienes; Anti-Allergic Agents; Dermatit | 2007 |
In vitro studies with fexofenadine, a new nonsedating histamine H1 receptor antagonist, on isolated human basophils.
Topics: Basophils; Dermatitis, Atopic; Enzyme Inhibitors; Histamine H1 Antagonists; Histamine Release; Human | 2000 |